Related Experiment Videos
Doping use among tertiary education students in six developed countries
Fotios C Papadopoulos1, Ilias Skalkidis, Jari Parkkari
1Department of Hygiene and Epidemiology, Athens University Medical School, 75 Mikras Asias str., Goudi, Athens, Greece.
European Journal of Epidemiology
|May 11, 2006
Summary
Doping use is prevalent in young adults, with 2.6% reporting use. Predictors include male gender, coffee consumption, and peer influence, highlighting a significant public health concern.
Area of Science:
- Sports Science
- Public Health
- Criminology
Background:
- Limited data exists on doping prevalence among young, non-professional athletes.
- Understanding doping patterns in this demographic is crucial for targeted interventions.
Purpose of the Study:
- To estimate the prevalence and identify predictors of doping use among tertiary education students.
- To compare doping rates across different European countries and Israel.
Main Methods:
- A standardized, anonymous questionnaire was self-administered to 2650 students across six countries.
- Statistical analysis included calculating odds ratios (OR) and 95% confidence intervals (CI) for various factors.
Main Results:
- The overall reported doping usage rate was 2.6%, with no significant country-specific variations.
- Doping was less common in biomedical students (OR: 0.49) and more prevalent in males (OR: 2.16).
- Factors associated with increased doping included coffee consumption, drunkenness episodes, nutritional supplement use, participation in major athletic events, and having a friend who uses doping (OR: 8.61).
Conclusions:
- Doping among young non-professional athletes is a significant issue, potentially as substantial as in professional athletes.
- High-risk behaviors, supplement use, and social influence (peer networks) are key predictors of doping.
- Interventions should address these risk factors within the broader young adult population.
Related Concept Videos
01:23Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
02:16Surveys
Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...